Péntek, Márta; Poór, Gyula; Wiland, Piotr; … - In: The European Journal of Health Economics 15 (2014) 1, pp. 35-43
Biological drugs revolutionized the treatment of inflammatory rheumatic diseases. Access to treatment presents substantial variability across Europe. The economic level of a particular country as well as administrative restrictions have been proved as determining factors of biological drug...